Kepos Capital LP Myriad Genetics Inc Transaction History

Kepos Capital LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$9.78 - $29.53 $214,035 - $646,264	-21,885 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$20.93 - $35.1 $286,364 - $480,238	-13,682 Reduced 38.47%	21,885 $596,000
Q3 2019 Nov 13, 2019	SELL	$22.08 - $47.08 $723,252 - $1.54 Million	-32,756 Reduced 47.94%	35,567 $1.02 Million
Q2 2019 Aug 13, 2019	SELL	$22.67 - $35.0 $22 - $35	-1 Reduced -0.0%	68,323 $1.9 Million
Q1 2019 May 13, 2019	SELL	$26.93 - $34.7 $678,043 - $873,676	-25,178 Reduced 26.93%	68,324 $2.27 Million
Q4 2018 Feb 13, 2019	BUY	$27.23 - $45.56 $447,715 - $749,097	16,442 Added 21.34%	93,502 $2.72 Million
Q3 2018 Nov 13, 2018	BUY	$37.57 - $50.34 $2.9 Million - $3.88 Million	77,060 New	77,060 $3.55 Million

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.23B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.